GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 72 filers reported holding GOSSAMER BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,408,000 | +1171.6% | 284,500 | +789.1% | 1.47% | +885.2% |
Q2 2022 | $268,000 | -80.2% | 32,000 | -73.3% | 0.15% | -73.9% |
Q4 2021 | $1,355,000 | -49.9% | 119,843 | -44.3% | 0.57% | -40.3% |
Q3 2021 | $2,703,000 | +107.9% | 215,000 | +258.3% | 0.95% | +54.4% |
Q1 2019 | $1,300,000 | – | 60,000 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |